Quantinno Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quantinno Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$383K	Buy	2,996 +1,057	+55%	+$132K	﹤0.01%	2896
2025 Q4	$236K	Sell	1,939 -355	-15%	-$40.7K	﹤0.01%	2974
2025 Q3	$230K	Buy	+2,294	New	+$207K	﹤0.01%	2664

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Quantinno Capital Management's XBI Position: Q1 2026 in Review

Quantinno Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 55% in Q1 2026, buying an estimated $132K and bringing the position to 2,996 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

Quantinno Capital Management first reported a position in XBI in Q3 2025 and has held it in 3 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Quantinno Capital Management held 2,996 shares of State Street SPDR S&P Biotech ETF worth $383K as of Q1 2026.
Quantinno Capital Management bought 1,057 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $132K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2896 holding.
Quantinno Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 3 quarters since.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.